Skip to main content

Nanosphere Signs Deal With Takara Bio For Distribution, Research

NEW YORK, July 23-Nanosphere said yesterday that it had formed a distribution and development agreement with the Japanese firm Takara Bio.

 

Under the agreement, Takara will be the exclusive Nanosphere distributor in Asia, and have non-exclusive distribution rights in Europe.

 

The two companies will also work to develop portable protein and nucleic acid identification systems that combine Nanosphere's DNA probe technology with Takara's gene amplification techniques.

 

Further, Takara will make an equity investment in Nanosphere.

 

Specific financial details of the agreement were not disclosed.

 

Nanosphere is a privately held assay firm based in Northbrook, Ill.

 

Takara Bio, based in Otsu, Japan, is a biotechnology subsidiary of Takara Holdings.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.